Clinical Trial

Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos

Study acronym: ESCALATE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 12, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the reproductive potential of embryos classified as "complex aneuploid" (involving three or more abnormal chromosomes) or "chaotic" (six or more abnormal chromosomes) through preimplantation genetic testing for aneuploidy (PGT-A). Specifically, we seek to determine whether embryos initially reported as having multiple chromosomal abnormalities might still have the potential for normal chromosomal composition, the opportunity for transfer, and ultimately, the potential to achieve a live birth through re-biopsy and reanalysis. Key Information: This portion of the study seeks your consent for the re-biopsy and genetic reanalysis of the embryos only. It does not yet include consent for potential future transfer. Participation remains completely voluntary, and your decision will not affect your current or future care. We deeply appreciate your support and commitment to advancing fertility research.
Trial Details
NCT Number NCT07227116
Lead Sponsor Shady Grove Fertility Reproductive Science Center
Conditions Complex Aneuploidy, Chaotic Aneuploidy
Enrollment 280 participants
Start Date 2025-11-01
Primary Completion 2026-04 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-11-12